1H-NMR-based urine metabolomics of prostate cancer and benign prostatic hyperplasia
Overdiagnosis
Rectal examination
Prostatic Diseases
DOI:
10.1016/j.heliyon.2024.e28949
Publication Date:
2024-03-31T21:52:12Z
AUTHORS (5)
ABSTRACT
Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are prevalent conditions affecting a significant portion of the male population, particularly with advancing age. Traditional diagnostic methods, such as digital rectal examination (DRE) prostate-specific antigen (PSA) tests, have limitations in specificity sensitivity, leading to potential overdiagnosis unnecessary biopsies.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (59)
CITATIONS (6)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....